E28.39
Other primary ovarian failure
Clinical Classification Guidelines
Inclusion Terms
- Decreased estrogen
- Resistant ovary syndrome
Medical Intelligence & Overview
Other primary ovarian failure, classified under ICD-10 code E28.39, is a condition characterized by the ovaries ceasing to function properly, leading to decreased production of reproductive hormones, especially estrogen. Unlike typical menopause that occurs naturally with aging, this condition can affect women at a younger age and is sometimes linked to resistant ovary syndrome, where ovaries do not respond to hormonal signals. This condition can impact fertility, menstrual cycles, and overall hormonal balance, making awareness and understanding important for management and support.
Causes & Symptoms
Clinical Causes: Genetic factors, such as Turner syndrome or fragile X premutation Autoimmune disorders where the immune system attacks ovarian tissue Chemotherapy or radiation therapy affecting ovarian function Surgical removal of ovaries or ovarian damage Infections, such as mumps oophoritis Endocrine disorders that disrupt hormonal regulation Resistant ovary syndrome, where ovaries are resistant to hormonal stimulation despite normal ovarian tissue
Key Symptoms: Irregular or absent menstrual periods (amenorrhea) Hot flashes and night sweats due to decreased estrogen Vaginal dryness and discomfort during intercourse Reduced libido or sexual desire Infertility or difficulty conceiving Mood swings or depression Bone density loss leading to osteoporosis over time Physical changes, such as thinning hair or skin changes
Diagnostic & Treatment
Diagnosis Path: The diagnosis of other primary ovarian failure involves a comprehensive medical evaluation, including a detailed medical history, physical examination, and specific laboratory tests. Blood tests measure levels of hormones like follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estrogen. Elevated FSH levels coupled with low estrogen typically indicate ovarian failure. Additionally, tests assessing ovarian reserve and genetic studies might be performed. Imaging, such as ultrasound, can evaluate ovarian size and presence of ovarian tissue to differentiate resistant ovary syndrome from other causes.
Treatment Protocols: Management of this condition is tailored to individual needs and aims to address hormonal deficiencies, manage symptoms, and support overall health. Hormone replacement therapy (HRT) is commonly used to mitigate menopausal symptoms and protect bone health. Fertility treatments, including assisted reproductive technologies like in-vitro fertilization (IVF), may be recommended for women wishing to conceive. Regular monitoring and lifestyle modifications, such as adequate calcium and vitamin D intake, help prevent osteoporosis. Counseling and support groups can assist with emotional and psychological challenges associated with reduced hormonal function.
Clinical Advice & FAQs
Billing Guidance
Is E28.39 a billable ICD-10 code?
Yes, E28.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E28.39?
Clinical documentation must specify the nature of Other primary ovarian failure and any associated comorbidities for accurate reporting.
Cite this Clinical Reference